Replies to post #2623 on Repros Therapeutics Inc (RPRX)

[rstor1]

OT

You are switching the subject. We are talking about what the rational decision was post-panel. My contention is that it was to sell.

In fact I sold about 75% of my holdings in DNDN at that time because I thought it went up too far without an FDA approval.

Anybody that made real money on it this year did the same.

So the allegation against Dew - that his advice re DNDN is worthless - is not correct.

Despite this, I disagree w/him on RPRX. My gut tells me Joe P is not a crook.

Back to our regular programming.